Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference

GAITHERSBURG, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer, Matthew Ferguson, Chief Financial Officer, and Dr. Michelle Williams Companies , Chief Scientific Officer, will participate in two upcoming Investor conferences.

Lake Street Capital Markets 10^th Annual Big Ideas Growth Conference
Elutia will host one-on-one meetings with investors at the Lake Street Capital Markets 10^th Annual Big Ideas Growth Conference at the Metropolitan Club in New York City on September 10, 2026. To schedule a one-on-one meeting, institutional investors may contact their Lake Street representative.

H.C. Wainwright 28^th Annual Global Investment Conference
Elutia will also present and host one-on-one meetings with investors at the H.C. Wainwright 28^th Annual Global Investment Conference at the Lotte New York Palace Hotel in New York City on September 15-16, 2026.

During the presentation, management will discuss how Elutia is working to address post-surgical infection in plastic and reconstructive surgeries—one of the most significant challenges facing patients and surgeons—through its drug-eluting biomatrix technology designed to support safer, more reliable reconstructive outcomes.

The presentation will begin at 7:00am Eastern Daylight Time on Friday, September 11, 2026, and can be accessed on-demand here: Webcast. Elutia will also host one-on-one meetings with investors on September 15-16, 2026. To schedule a one-on-one meeting, visit H.C. Wainwright.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia's mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Elutia Investor Relations
ir@elutia.com